Doctors petition Big 12 and NCAA to pause Monster Energy sponsorship over children’s health concerns

The Big 12 Conference is facing outside pressure to reconsider its newly expanded sponsorship relationship with Monster Energy after a group of physicians and scientists petitioned the conference and the NCAA to pause the rollout. The petition argues that energy drinks are a health risk for children and that high-visibility marketing linked to youth are an unacceptable step in the absence of safeguards.

According to the report, the doctors and scientists are asking both governing bodies to stop or delay the advertising expansion while the matter is reviewed. Their stated concern is not limited to individual consumption, but to the broader effect of advertising and normalization of energy drinks among younger audiences who may be exposed through collegiate sports venues, broadcasts, and related media.

Energy drinks are widely regulated in the United States, but the petition frames the issue as a public health question tied to marketing practices rather than a simple compliance issue. The doctors’ position, as described by Yahoo Sports, is that Big 12’s partnership goes too far because it increases children’s exposure to products that can contain stimulant ingredients and substantial caffeine.

The Big 12’s sponsorship strategy matters because it represents a major element of how conferences finance athletics and rights packages, including through brand partnerships that can reach far beyond game day. For the conference, aligning with a widely recognizable national brand also reflects the modern sports sponsorship environment, where leagues attempt to maximize revenue streams across media platforms and fan touchpoints.

This petition also lands in a wider debate that has followed energy-drink marketing for years, including questions about labeling, age targeting, and the practical limits of “adult consumption” messaging when the surrounding environment includes families and minors. The coalition’s request to pause the rollout is essentially an attempt to move the dispute from consumer behavior to the responsibilities of institutions managing visibility and reach.

As of now, there is no indication in the reporting that the Big 12 or NCAA has agreed to a pause. The most immediate question for fans and administrators is whether the conference will respond formally, whether the NCAA will take up the request, and what criteria any review would apply, especially given the NCAA’s role as a governance body rather than a direct marketer.

For observers of college football, the broader watch point is how quickly health and sponsorship disputes can become part of institutional risk management. If the petition gains traction, it may encourage other conferences, schools, and media partners to revisit brand relationships that place stimulant products in prominent settings, even when those products are marketed under existing legal frameworks. If the request is denied or ignored, the case may still influence how schools evaluate sponsorship proposals involving youth-facing exposure.